278 related articles for article (PubMed ID: 23596523)
1. Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence.
Kumar R; Raghava GP
PLoS One; 2013; 8(4):e61437. PubMed ID: 23596523
[TBL] [Abstract][Full Text] [Related]
2. A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.
Döring M; Borrego P; Büch J; Martins A; Friedrich G; Camacho RJ; Eberle J; Kaiser R; Lengauer T; Taveira N; Pfeifer N
Retrovirology; 2016 Dec; 13(1):85. PubMed ID: 27998283
[TBL] [Abstract][Full Text] [Related]
3. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization.
Polzer S; Dittmar MT; Schmitz H; Schreiber M
Virology; 2002 Dec; 304(1):70-80. PubMed ID: 12490404
[TBL] [Abstract][Full Text] [Related]
4. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
Kato K; Sato H; Takebe Y
J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
[TBL] [Abstract][Full Text] [Related]
5. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
[TBL] [Abstract][Full Text] [Related]
6. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
7. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.
Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA
J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813
[TBL] [Abstract][Full Text] [Related]
8. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.
Cardozo T; Kimura T; Philpott S; Weiser B; Burger H; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):415-26. PubMed ID: 17411375
[TBL] [Abstract][Full Text] [Related]
10. Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods.
Kalu AW; Telele NF; Aralaguppe SG; Gebre-Selassie S; Fekade D; Marrone G; Sonnerborg A
Curr HIV Res; 2018; 16(2):113-120. PubMed ID: 29766813
[TBL] [Abstract][Full Text] [Related]
11. Higher prevalence of predicted X4-tropic strains in perinatally infected older children with HIV-1 subtype C in India.
Neogi U; Sahoo PN; Arumugam K; Sonnerborg A; De Costa A; Shet A
J Acquir Immune Defic Syndr; 2012 Apr; 59(4):347-53. PubMed ID: 22107818
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.
Xiang SH; Pacheco B; Bowder D; Yuan W; Sodroski J
Virology; 2013 Mar; 438(1):5-13. PubMed ID: 23369572
[TBL] [Abstract][Full Text] [Related]
13. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
[TBL] [Abstract][Full Text] [Related]
15. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.
Antell GC; Dampier W; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; Schwartz G; Hershberg U; Krebs FC; Wigdahl B
Retrovirology; 2016 May; 13(1):32. PubMed ID: 27143130
[TBL] [Abstract][Full Text] [Related]
16. Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage.
Masso M; Vaisman II
BMC Bioinformatics; 2010 Oct; 11():494. PubMed ID: 20923564
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.
Jiang X; Feyertag F; Meehan CJ; McCormack GP; Travers SA; Craig C; Westby M; Lewis M; Robertson DL
J Virol; 2015 Nov; 89(22):11457-72. PubMed ID: 26339063
[TBL] [Abstract][Full Text] [Related]
18. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1.
Heger E; Thielen A; Gilles R; Obermeier M; Lengauer T; Kaiser R; Trapp S
Med Microbiol Immunol; 2012 Feb; 201(1):7-16. PubMed ID: 21573951
[TBL] [Abstract][Full Text] [Related]
20. Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.
Dimonte S; Mercurio F; Svicher V; D'Arrigo R; Perno CF; Ceccherini-Silberstein F
Retrovirology; 2011 May; 8():33. PubMed ID: 21569409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
